Literature DB >> 8423226

Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.

K Egashira1, T Inou, Y Hirooka, A Yamada, Y Maruoka, H Kai, M Sugimachi, S Suzuki, A Takeshita.   

Abstract

We examined whether coronary risk factors and atherosclerotic lesions in the study artery were associated with impaired endothelium-dependent dilation of coronary resistance arteries. Acetylcholine (ACH) at graded doses (1, 3, 10 and 30 micrograms/min) and papaverine (10 mg) were selectively infused into the left anterior descending coronary artery of 28 patients, in whom the study artery was angiographically normal (n = 16) or with mild stenosis < or = 40% (n = 12). Coronary blood flow (CBF) was estimated from the product of mean CBF velocity measured by an intracoronary Doppler catheter and the arterial cross-sectional area of the study artery determined by quantitative arteriography. ACH increased CBF in a dose-dependent manner. However, the maximum CBF response to ACH varied widely among patients (from 50% to 660%). By multivariate analysis, the presence of atherosclerotic lesions in the study artery was an independent predictor for impaired CBF response to ACH (P < 0.01). Hypertension (P < 0.001), hypercholesterolemia (r = -0.52, P < 0.005), age > or = 50 yr (P < 0.01) and total number of coronary risk factors (r = -0.62, P < 0.001) were associated with the impaired increase in CBF with ACH by univariate analysis. The percent increase in CBF evoked with papaverine did not correlate with these risk factors. The results suggest that mild atherosclerotic lesions in the study artery and coronary risk factors are accompanied by impaired endothelium-dependent dilation of coronary resistance arteries evoked with ACH. Endothelial dysfunction of coronary resistance arteries may result in altered regulation of myocardial perfusion in patients with mild coronary atherosclerosis and coronary risk factors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423226      PMCID: PMC329991          DOI: 10.1172/JCI116183

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.

Authors:  P L Ludmer; A P Selwyn; T L Shook; R R Wayne; G H Mudge; R W Alexander; P Ganz
Journal:  N Engl J Med       Date:  1986-10-23       Impact factor: 91.245

2.  Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta.

Authors:  H E Andrews; K R Bruckdorfer; R C Dunn; M Jacobs
Journal:  Nature       Date:  1987 May 21-27       Impact factor: 49.962

3.  Microvascular distribution of coronary vascular resistance in beating left ventricle.

Authors:  W M Chilian; C L Eastham; M L Marcus
Journal:  Am J Physiol       Date:  1986-10

4.  Attenuation of endothelium-related relaxation and enhanced responsiveness of vascular smooth muscle to histamine in spastic coronary arterial segments from miniature pigs.

Authors:  Y Yamamoto; H Tomoike; K Egashira; M Nakamura
Journal:  Circ Res       Date:  1987-12       Impact factor: 17.367

5.  Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans.

Authors:  R F Wilson; C W White
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

6.  Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease.

Authors:  G M Rubanyl; R L Frye; D R Holmes; P M Vanhoutte
Journal:  J Am Coll Cardiol       Date:  1987-06       Impact factor: 24.094

7.  Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110.

Authors:  J B Habib; C Bossaller; S Wells; C Williams; J D Morrisett; P D Henry
Journal:  Circ Res       Date:  1986-02       Impact factor: 17.367

8.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

9.  EDRF coordinates the behaviour of vascular resistance vessels.

Authors:  T M Griffith; D H Edwards; R L Davies; T J Harrison; K T Evans
Journal:  Nature       Date:  1987 Oct 1-7       Impact factor: 49.962

10.  Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta.

Authors:  C Bossaller; G B Habib; H Yamamoto; C Williams; S Wells; P D Henry
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

View more
  46 in total

1.  Effect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms.

Authors:  A P Mansur; C V Serrano; J C Nicolau; L A César; J A Ramires
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

2.  Effect of L-arginine administration on myocardial thallium-201 perfusion during exercise in patients with angina pectoris and normal coronary angiograms.

Authors:  H Fujita; H Yamabe; M Yokoyama
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 3.  Aspirin in patients with coronary artery disease: is it simply irresistible?

Authors:  G V Nair; C J Davis; M E McKenzie; D R Lowry; V L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

Review 4.  Coagulation syndrome: Delayed perforation after colorectal endoscopic treatments.

Authors:  Kingo Hirasawa; Chiko Sato; Makomo Makazu; Hiroaki Kaneko; Ryosuke Kobayashi; Atsushi Kokawa; Shin Maeda
Journal:  World J Gastrointest Endosc       Date:  2015-09-10

5.  The prevalence of endothelial dysfunction in patients with and without coronary artery disease.

Authors:  Stefan Toggweiler; Andreas Schoenenberger; Nadja Urbanek; Paul Erne
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

Review 6.  Essential Hypertension and Functional Microvascular Ageing.

Authors:  Rosa Maria Bruno; Stefano Masi; Marco Taddei; Stefano Taddei; Agostino Virdis
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-01-09

Review 7.  Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk.

Authors:  Todd J Anderson
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

Review 8.  Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.

Authors:  Christine R Culy; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

Authors:  A A Quyyumi; N Dakak; N P Andrews; S Husain; S Arora; D M Gilligan; J A Panza; R O Cannon
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Rare Case of Iatrogenic Myocardial Infarction Induced by Use of Pyridostigmine.

Authors:  Muhammad Niazi; Qasim Z Iqbal; Zeeshan Zia; Saud Bin Abdul Sattar; James Lafferty
Journal:  Cureus       Date:  2020-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.